ITAT Ahmedabad ruled that a notice under section 148 issued beyond the statutory period is invalid, quashing a ₹115 crore reassessment of a share-trading company. The Tribunal emphasized adherence to ...
- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention that ...
- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention that ...
Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab has been approved by the European Commission (EC) for all previously approved indications for ...
Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Formulation Development Outsourcing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
Odisha's state cabinet has approved new rules to combat illegal mining and regulate mineral trade, replacing the 2007 framework. The Odisha Minerals (Prevention of Illegal Mining and Regulation of ...
MIAMI - Pasithea Therapeutics Corp. (NASDAQ:KTTA) announced Friday positive pharmacokinetic (PK) data from its ongoing Phase 1/1b study of PAS-004 tablet formulation in adult patients with ...
Aston University's Dr Jonathan Cox and New Zealand Mānuka honey company Comvita have announced a significant milestone in their three-year research collaboration, with the filing of a new patent for a ...
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced positive results from its pivotal bioequivalence (BE) study evaluating pitolisant ...
INCHEON, South Korea--(BUSINESS WIRE)--Celltrion, Inc. today announced that the European Commission (EC) has granted marketing authorization for Remsima™ IV (intravenous) liquid formulation, the world ...
The Danish pharmaceutical giant Novo Nordisk finds itself navigating turbulent market conditions. Following a significant clinical setback and sustained share price erosion, the company is now ...
Trump's $100,000 H-1B visa fee draws legal challenge from California, other states California and other U.S. states will file a lawsuit on Friday seeking to block President Donald Trump's $100,000 fee ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback